From: Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles
Nanomaterial
HD (nm)
PDI
ZP (ζ)
PTX NPs
141.8 ± .6
.155 ± .009
−7.6 ± .2
FDA NPs
171.3 ± 1.2
.129 ± .004
−6.4 ± .2
NR NPs
209.3 ± .6
.175 ± .007
−6.7 ± .1
ICG NPs
180.7 ± .9
.076 ± .006
−6.8 ± .1